Mineral

    Vanadium

    Vanadyl sulfate / vanadium

    TL;DR

    Vanadium really does mimic insulin biochemically — the problem is that the doses that move blood glucose in humans sit close to the doses that cause gastrointestinal and possible renal harm.

    Ideal For

    • No population is well supported at supplemental doses

    Avoid If

    • You have any kidney impairment
    • You are looking for blood sugar control — safer options exist

    Frequently Asked Questions

    Overview

    Vanadium compounds inhibit protein tyrosine phosphatase 1B, the enzyme that switches off the insulin receptor, so vanadium leaves insulin signalling active for longer. In diabetic rodents this produces striking glucose lowering, which drove a wave of interest in the 1990s. Human trials never matched it. The studies are tiny — typically 5 to 15 participants, unblinded, lasting a few weeks — and used 50-300 mg/day of vanadyl sulfate, hundreds of times the trace amount in food. A Cochrane review concluded there is no rigorous evidence supporting vanadium for diabetes, and the trials that reported improved insulin sensitivity were too small and too poorly controlled to rely on. Meanwhile the safety margin is genuinely narrow: gastrointestinal intolerance is near universal at effective doses, the tolerable upper intake level is set at 1.8 mg/day for adults, and animal work raises renal and haematologic concerns. This is a case where the mechanism is real and the therapeutic window is not.

    How It Works

    • Inhibits protein tyrosine phosphatase 1B, prolonging insulin receptor signalling
    • Activates PI3K/Akt glucose uptake pathways independent of insulin
    • Accumulates in bone, kidney and liver with chronic dosing

    Quick Facts

    • Tolerable upper limit is 1.8 mg/day; trials used 50-300 mg/day
    • Cochrane found no rigorous evidence for diabetes
    • Green tongue discoloration is a common sign of high intake

    Benefits & Outcomes

    No linked outcomes yet. Research is ongoing.

    Health Concerns Addressed

    Type 2 Diabetes

    condition
    Not supported
    Effectiveness 1/5

    The mechanism is real and the therapeutic window is not — Cochrane found no rigorous evidence, and effective doses sit above established safety limits.

    Supporting Research
    6 studies

    A systematic review of vanadium oral supplements for glycaemic control in type 2 diabetes mellitus

    Score: 8/10
    2008
    systematic_review
    n=40

    Smith DM, Pickering RM, Lewith GT

    There was no good evidence that oral vanadium supplementation improved glycaemic control in diabetes and so the routine use of vanadium could not be recommended.

    View source

    Vanadyl sulfate improves hepatic and muscle insulin sensitivity in type 2 diabetes

    Score: 5/10
    2001
    rct
    n=11

    Cusi K, Cukier S, DeFronzo RA +3 more

    Vanadyl sulfate improved hepatic and muscle insulin sensitivity in patients with type 2 diabetes.

    View source

    Metabolic effects of vanadyl sulfate in humans with non-insulin-dependent diabetes mellitus

    Score: 6/10
    2000
    rct
    n=16

    Goldfine AB, Patti ME, Zuberi L +3 more

    Modest reductions in fasting glucose occurred only at the higher vanadyl sulfate dose, with dose-limiting gastrointestinal effects.

    View source

    Effect of vanadium on insulin sensitivity in patients with impaired glucose tolerance

    Score: 6/10
    2008
    rct
    n=14

    Jacques-Camarena O, González-Ortiz M, Martínez-Abundis E +2 more

    Vanadium supplementation did not modify insulin sensitivity in patients with impaired glucose tolerance.

    View source

    Vanadium compounds with antidiabetic potential

    Score: 5/10
    2023
    systematic_review

    Amaral LMPF, Silva AMN

    Insulin-mimetic activity is well documented in animal models, but human trials remain small and confounded by toxicity concerns.

    View source

    The effect of oral vanadyl sulfate on body composition and performance in weight-training athletes

    Score: 6/10
    1996
    rct
    n=31

    Fawcett JP, Farquhar SJ, Walker RJ +3 more

    Oral vanadyl sulfate had no effect on body composition in weight-training athletes.

    View source

    Safety Information

    Potential Side Effects

    Nausea, abdominal cramping, diarrhoea, green tongue. Chronic high intake raises renal and haematologic concerns.

    Contraindications

    Kidney disease, pregnancy, lactation. Caution in anyone on glucose-lowering medication.

    Drug Interactions

    • Insulin and sulfonylureas — additive hypoglycemia risk
    • Anticoagulants — possible additive effect

    Pregnancy & Breastfeeding

    Pregnancy: unsafe

    Breastfeeding: unsafe

    Dosage Guidelines

    Dosage Used in Studies

    Consult healthcare provider

    Best Time to Take

    Not applicable

    Best Form

    Dietary intake from mushrooms, shellfish, black pepper and grains

    Bioavailability

    Under 5% oral absorption for vanadyl sulfate; accumulates in bone with chronic use

    Forms Compared

    Most common; poorly absorbed and GI-irritating

    Better absorbed research compound; not established for consumer use

    Food & Timing

    With food if taken at all

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.